Atlas Trials

Clinical Study of Subretinal Transplantation of Human Embryo Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Macular Degeneration Diseases

Clinical trial NCT02749734 · UNKNOWN

Trial details

NCT number
NCT02749734
Sponsor
Southwest Hospital, China
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Macular DegenerationStargardt's Macular Dystrophy
Start date
2015-05-01
Primary completion
2018-12-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.